Anti-CORT/ CST-14/ CST-17 functional antibody

Anti-CORT/ CST-14/ CST-17 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to CORT/CORT products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0811-Ab-1/ GM-Tg-hg-SE0811-Ab-2Anti-Human CORT monoclonal antibodyHuman
GM-Tg-rg-SE0811-Ab-1/ GM-Tg-rg-SE0811-Ab-2Anti-Rat CORT monoclonal antibodyRat
GM-Tg-mg-SE0811-Ab-1/ GM-Tg-mg-SE0811-Ab-2Anti-Mouse CORT monoclonal antibodyMouse
GM-Tg-cynog-SE0811-Ab-1/ GM-Tg-cynog-SE0811-Ab-2Anti-Cynomolgus/ Rhesus macaque CORT monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0811-Ab-1/ GM-Tg-felg-SE0811-Ab-2Anti-Feline CORT monoclonal antibodyFeline
GM-Tg-cang-SE0811-Ab-1/ GM-Tg-cang-SE0811-Ab-2Anti-Canine CORT monoclonal antibodyCanine
GM-Tg-bovg-SE0811-Ab-1/ GM-Tg-bovg-SE0811-Ab-2Anti-Bovine CORT monoclonal antibodyBovine
GM-Tg-equg-SE0811-Ab-1/ GM-Tg-equg-SE0811-Ab-2Anti-Equine CORT monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0811-Ab-1/ GM-Tg-hg-SE0811-Ab-2; GM-Tg-rg-SE0811-Ab-1/ GM-Tg-rg-SE0811-Ab-2;
GM-Tg-mg-SE0811-Ab-1/ GM-Tg-mg-SE0811-Ab-2; GM-Tg-cynog-SE0811-Ab-1/ GM-Tg-cynog-SE0811-Ab-2;
GM-Tg-felg-SE0811-Ab-1/ GM-Tg-felg-SE0811-Ab-2; GM-Tg-cang-SE0811-Ab-1/ GM-Tg-cang-SE0811-Ab-2;
GM-Tg-bovg-SE0811-Ab-1/ GM-Tg-bovg-SE0811-Ab-2; GM-Tg-equg-SE0811-Ab-1/ GM-Tg-equg-SE0811-Ab-2
Products NameAnti-CORT monoclonal antibody
Formatmab
Target NameCORT
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Diagnostic target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CORT benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0811-Ag-1Recombinant multi-species CORT/ CST-14/ CST-17 protein


    Target information

    Target IDGM-SE0811
    Target NameCORT
    Gene ID1325,12854,114674163
    Gene Symbol and SynonymsCORT,CST,CST-14,CST-17,CST-29,PCST,SST2
    Uniprot AccessionO00230
    Uniprot Entry NameCORT_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryDiagnostics Biomarker
    DiseaseN/A
    Gene EnsemblENSG00000241563
    Target ClassificationN/A

    The target: CORT, gene name: CORT, also named as CST-14, CST-17, CST-29. This gene encodes a neuropeptide that is structurally similar to somatostatin. It binds to all known somatostatin receptors, and shares many pharmacological and functional properties with somatostatin, including the depression of neuronal activity. However, it also has many properties distinct from somatostatin, such as induction of slow-wave sleep, apparently by antagonism of the excitatory effects of acetylcholine on the cortex, reduction of locomotor activity, and activation of cation selective currents not responsive to somatostatin. The preproprotein undergoes further processing into multiple mature products. Read-through transcripts exist between this gene and the upstream APITD1 (apoptosis-inducing, TAF9-like domain 1) gene, as represented in GeneID:100526739. [provided by RefSeq, Nov 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.